The DOI matches its Crossref record; 112 of the 116 references it cites were found in a registry or an index.
Structure, function, and biology of SHIP proteins
Abstract
One of the “simple” curiosities of life, at least for a biological scientist, is how the growth and development of a complete organism from a single cell is controlled. Part of the answer includes growth factor receptors and their respective ligands, which transduce signals across cell membranes and into the nucleus for transcriptional readout. The molecular nature of these intracellular signals determines the type of signals, the pathways involved, subsequent regulatory interactions, and eventual transcription factor activation/repression. Hematopoietic cell development has been a fruitful system for the
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This lipid dephosphorylation reaction prevents receptor activation, mitigating signal transduction through the phosphatidylinositol-3-kinase/mammalian target of rapamycin (PI3K/mTOR) pathway.10”
From Microglial INPP5D limits plaque formation and glial reactivity in the PSAPP mouse model of Alzheimer's disease (2023) · cites this paper as [10]
In the citing paper
“SHIP1 negatively regulates targets such as immune cell surface receptors by catalyzing the conversion of phosphatidylinositol (3,4,5)-trisphosphate (PI[3,4,5]P3) to phosphatidylinositol (3,4)-bisphosphate (PI[3,4]P2).”
From Microglial INPP5D limits plaque formation and glial reactivity in the PSAPP mouse model of Alzheimer's disease (2023) · cites this paper as [10]
In the citing paper
“The inositol polyphosphate-5-phosphatase D (INPP5D) gene encodes a dual-specificity phosphatase that can dephosphorylate both phospholipids and phosphoproteins.”
From Microglial INPP5D limits plaque formation and glial reactivity in the PSAPP mouse model of Alzheimer's disease (2023) · cites this paper as [10]
In the citing paper
“SHIP1 was originally observed in hematopoietic cells after a variety of cytokines and growth factors induced the tyrosine phosphorylation of this 145-kDa protein [98–104].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [104]
Citations
Cites
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0497-356 · Cited by 2,742
SH2 domains recognize specific phosphopeptide sequences
Songyang, Z. (1993) · Cell · doi:10.1016/0092-8674(93)90404-e · Cited by 2,620
Signal Transduction through MAP Kinase Cascades
Lewis, T. S., Shapiro, P. S., & Ahn, N. G. (1998) · Advances in cancer research · doi:10.1016/s0065-230x(08)60765-4 · Cited by 1,759
Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease
Durbin, J. E., Hackenmiller, R., Simon, M. C., & Levy, D. E. (1996) · Cell · doi:10.1016/s0092-8674(00)81289-1 · Cited by 1,539
Pten is essential for embryonic development and tumour suppression
Cristofano, A. D., Pesce, B., Cordon‐Cardo, C., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/1235 · Cited by 1,518
Stephens, L., Anderson, K. E., Stokoe, D., Erdjument‐Bromage, H., Painter, G. F., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., McCormick, F. P., Tempst, P., et al. (1998) · Science · doi:10.1126/science.279.5351.710 · Cited by 1,061
Specific Inhibition of Stat3 Signal Transduction by PIAS3
Chung, C. D., Liao, J., Liu, B., Rao, X., Jay, P., Berta, P., & Shuai, K. (1997) · Science · doi:10.1126/science.278.5344.1803 · Cited by 980
Rozakis-Adcock, M., McGlade, J. C., Mbamalu, G., Pelicci, G., Daly, R. J., Li, W., Batzer, A., Thomas, S. Μ., Brugge, J. S., Pelicci, P. G., et al. (1992) · Nature · doi:10.1038/360689a0 · Cited by 973
Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems
Podsypanina, K., Ellenson, L. H., Nemes, A., Gu, J., Tamura, M., Yamada, K. M., Cordon‐Cardo, C., Cattoretti, G., Fisher, P. E., & Parsons, R. E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1563 · Cited by 947
Cited by
Sorted by citations
Genetic regulation of osteoclast development and function
Teitelbaum, S. L., & Ross, F. P. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1122 · Cited by 1,720
The protein kinase B/Akt signalling pathway in human malignancy
Nicholson, K. M., & Anderson, N. G. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00271-6 · Cited by 1,665
Phosphoinositides: Tiny Lipids With Giant Impact on Cell Regulation
Balla, T. (2013) · Physiological Reviews · doi:10.1152/physrev.00028.2012 · Cited by 1,638
Synthesis and Function of 3-Phosphorylated Inositol Lipids
Vanhaesebroeck, B., Leevers, S. J., Ahmadi, K., Timms, J., Katso, R., Driscoll, P. C., Woscholski, R., Parker, P. J., & Waterfield, M. D. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.535 · Cited by 1,535
Ravetch, J. V., & Lanier, L. L. (2000) · Science · doi:10.1126/science.290.5489.84 · Cited by 1,278
Structure, regulation and function of PKB/AKT—a major therapeutic target
Hanada, M., Feng, J., & Hemmings, B. A. (2003) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2003.11.009 · Cited by 739
JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis
Steelman, L. S., Pohnert, S. C., Shelton, J. G., Franklin, R. A., Bertrand, F. E., & McCubrey, J. A. (2004) · Leukemia · doi:10.1038/sj.leu.2403241 · Cited by 705
Signaling Cross Talk between TGF-β/Smad and Other Signaling PathwaysPreprint
Luo, K. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022137 · Cited by 671
Targeting phosphoinositide 3-kinase—Moving towards therapy
Marone, R., Cmiljanović, V., Giese, B., & Wymann, M. P. (2007) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2007.10.003 · Cited by 560
Signalling through Class I PI3Ks in mammalian cells
Hawkins, P. T., Anderson, K. E., Davidson, K., & Stephens, L. R. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340647 · Cited by 540
Phosphoinositide 3-kinase signalling pathways
Cantrell, D. A. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.8.1439 · Cited by 539
Oncogenic PI3K and its role in cancer
Samuels, Y., & Ericson, K. (2005) · Current Opinion in Oncology · doi:10.1097/01.cco.0000198021.99347.b9 · Cited by 519
Crk family adaptors–signalling complex formation and biological roles
Feller, S. M. (2001) · Oncogene · doi:10.1038/sj.onc.1204779 · Cited by 468
Bhattacharyya, R. P., Reményi, A., Yeh, B. J., & Lim, W. A. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142710 · Cited by 458
PTEN function: how normal cells control it and tumour cells lose it
Leslie, N. R., & Downes, C. P. (2004) · Biochemical Journal · doi:10.1042/bj20040825 · Cited by 447
PTEN: The down side of PI 3-kinase signalling
Leslie, N. R., & Downes, C. P. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00234-0 · Cited by 415
Regulation of myeloid development and function by colony stimulating factors
Barreda, D. R. (2003) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2003.09.010 · Cited by 416
Phosphoinositide signalling in cancer: beyond PI3K and PTEN
Bunney, T. D., & Katan, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2842 · Cited by 400
P hosphoinositide 3-K inase : Diverse Roles in Immune Cell Activation
Deane, J. A., & Fruman, D. A. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104721 · Cited by 347
Ueki, K., Fruman, D. A., Brachmann, S. M., Tseng, Y., Cantley, L. C., & Kahn, C. R. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.3.965-977.2002 · Cited by 285
Takeshita, S., Namba, N., Zhao, J. J., Jiang, Y., Genant, H. K., Silva, M. J., Brodt, M. D., Helgason, C. D., Kalesnikoff, J., Rauh, M. J., et al. (2002) · Nature Medicine · doi:10.1038/nm752 · Cited by 250
Negative Regulation of Immunoreceptor Signaling
Veillette, A., Latour, S., & Davidson, D. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.081501.130710 · Cited by 242
Phosphoinositides : key players in cell signalling, in time and space
Payrastre, B., Missy, K., Giuriato, S., Bodin, S., Plantavid, M. M., & Gratacap, M. (2001) · Cellular Signalling · doi:10.1016/s0898-6568(01)00158-9 · Cited by 224
Understanding PTEN regulation: PIP2, polarity and protein stability
Leslie, N. R., Batty, I. H., Maccario, H., Davidson, L., & Downes, C. P. (2008) · Oncogene · doi:10.1038/onc.2008.243 · Cited by 221
miR-155 regulates IFN-γ production in natural killer cells
Trotta, R., Chen, L., Ciarlariello, D., Josyula, S., Mao, C., Costinean, S., Yu, L., Butchar, J. P., Tridandapani, S., Croce, C. M., et al. (2012) · Blood · doi:10.1182/blood-2011-12-398099 · Cited by 204
Molecular mechanisms of transformation by the BCR-ABL oncogene
Sattler, M., & Griffin, J. D. (2003) · Seminars in Hematology · doi:10.1053/shem.2003.50034 · Cited by 205
BMP4 and Madh5 regulate the erythroid response to acute anemia
Lenox, L. E., Perry, J. M., & Paulson, R. F. (2005) · Blood · doi:10.1182/blood-2004-02-0703 · Cited by 197
Phosphoinositide signaling disorders in human diseases
Pendaries, C., Tronchère, H., Plantavid, M. M., & Payrastre, B. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00437-x · Cited by 197
Regulation of integrin-mediated cellular responses through assembly of a CAS/Crk scaffold
Chodniewicz, D., & Klemke, R. L. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.03.006 · Cited by 201
Akt/PKB: one kinase, many modifications
Risso, G., Blaustein, M., Pozzi, B., Mammi, P., & Srebrow, A. (2015) · Biochemical Journal · doi:10.1042/bj20150041 · Cited by 191
Luo, J., Field, S. J., Lee, J. Y., Engelman, J. A., & Cantley, L. C. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200503088 · Cited by 174
Shaw, L. M. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.15.5082-5093.2001 · Cited by 172
Activin/TGF-β induce apoptosis through Smad-dependent expression of the lipid phosphatase SHIP
Valderrama-Carvajal, H., Cocolakis, E., Lacerte, A., Lee, E., Krystal, G., Ali, S., & Lebrun, J. J. (2002) · Nature Cell Biology · doi:10.1038/ncb885 · Cited by 169
Inhibitory Receptors on Lymphocytes: Insights from Infections
Odorizzi, P. M., & Wherry, E. J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1100038 · Cited by 175
Cox, D., Dale, B. M., Kashiwada, M., Helgason, C. D., & Greenberg, S. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.1.61 · Cited by 158
Phosphatases in cell–matrix adhesion and migration
Larsen, M., Tremblay, M. L., & Yamada, K. M. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1199 · Cited by 143
Zhuang, G., Hunter, S., Hwang, Y., & Chen, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608509200 · Cited by 139
Isoform-specific phosphoinositide 3-kinase inhibitors as therapeutic agents
Ward, S. G. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(03)00078-x · Cited by 139
PI 3-K and T-cell activation: limitations of T-leukemic cell lines as signaling models
Astoul, E. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)01973-1 · Cited by 133
Kalesnikoff, J., Baur, N., Leitges, M., Hughes, M. R., Damen, J. E., Huber, M., & Krystal, G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4737 · Cited by 130
In vivo analysis of 3-phosphoinositide dynamics during Dictyostelium phagocytosis and chemotaxis
Dormann, D., Weijer, G., DOWLER, S., & Weijer, C. J. (2004) · Journal of Cell Science · doi:10.1242/jcs.01579 · Cited by 131
The tumor suppressor activity of SOCS-1
Rottapel, R. K., Ilangumaran, S., Neale, C., Rose, J. L., Ho, J., Nguyen, M. H.-H., Barber, D. L., Dubreuil, P. C., & Sepulveda, P. D. (2002) · Oncogene · doi:10.1038/sj.onc.1205537 · Cited by 129
Possible dominant-negative mutation of the SHIP gene in acute myeloid leukemia
Luo, J.-M., Yoshida, H., Komura, S., Ohishi, N., Pan, L., Shigeno, K., Hanamura, I., Miura, K., Iida, S., Ueda, R., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2402725 · Cited by 127
PI3K inhibition in inflammation: Toward tailored therapies for specific diseases
Ghigo, A., Damilano, F., Braccini, L., & Hirsch, E. (2010) · BioEssays · doi:10.1002/bies.200900150 · Cited by 126
PTEN in Neural Precursor Cells: Regulation of Migration, Apoptosis, and Proliferation
Li, L., Liu, F., Salmonsen, R. A., Turner, T. K., Litofsky, N. S., Cristofano, A. D., Pandolfi, P. P., Jones, S. N., Recht, L. D., & Ross, A. H. (2002) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2002.1115 · Cited by 125
Therapeutic Potential of Phosphoinositide 3-Kinase Inhibitors
Ward, S. G., Sotsios, Y., Dowden, J., Bruce, I., & Finan, P. M. (2003) · Chemistry & Biology · doi:10.1016/s1074-5521(03)00048-6 · Cited by 124
Phosphoinositide-Regulated Kinases and Phosphoinositide Phosphatases
Leslie, N. R., Biondi, R. M., & Alessi, D. R. (2001) · Chemical Reviews · doi:10.1021/cr000091i · Cited by 121
3'-phosphoinositide-dependent kinase-1 (PDK-1) in PI 3-kinase signaling
Störz, P. (2002) · Frontiers in bioscience · doi:10.2741/storz · Cited by 119
Freeburn, R. W., Wright, K. L., Burgess, S., Astoul, E., Cantrell, D. A., & Ward, S. G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5441 · Cited by 121
Crow, A. R., Song, S. M., Freedman, J. J., Helgason, C. D., Humphries, R. K., Siminovitch, K. A., & Lazarus, A. H. (2003) · Blood · doi:10.1182/blood-2003-01-0023 · Cited by 119
Pauls, S. D., & Marshall, A. J. (2017) · European Journal of Immunology · doi:10.1002/eji.201646795 · Cited by 118
Lipid phosphatases as drug discovery targets for type 2 diabetes
Lazar, D. F., & Saltiel, A. R. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2007 · Cited by 114
Phosphoinositide phosphatases in cell biology and disease
Yang, L., & Bankaitis, V. A. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.12.001 · Cited by 128
Vonakis, B. M., Vasagar, K., Gibbons, S. P., Gober, L. M., Sterba, P. M., Chang, H., & Saini, S. S. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.09.035 · Cited by 116
Inhibitor and activator: dual functions for SHIP in immunity and cancer
Kerr, W. G. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05869.x · Cited by 112
Fuhler, G. M., Brooks, R., Toms, B., Iyer, S., Gengo, E. A., Park, M.-Y., Gumbleton, M., Viernes, D. R., Chisholm, J. D., & Kerr, W. G. (2012) · Molecular Medicine · doi:10.2119/molmed.2011.00178 · Cited by 109
Phosphoinositide 3-kinases in T lymphocyte activation
Ward, S. G., & Cantrell, D. A. (2001) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00223-5 · Cited by 107
Tsai, A. P., Lin, P. B.-C., Dong, C., Moutinho, M., Casali, B. T., Liu, Y., Lamb, B. T., Landreth, G. E., Oblak, A. L., & Nho, K. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105303 · Cited by 104
Self-citationImmunoreceptors on neutrophils
van Rees, D. J., Szilagyi, K., Kuijpers, T. W., Matlung, H. L., & van den Berg, T. K. (2016) · Seminars in Immunology · doi:10.1016/j.smim.2016.02.004 · Cited by 100
Tarasenko, T., Kole, H. K., Chi, A. W., Mentink‐Kane, M. M., Wynn, T. A., & Bolland, S. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704853104 · Cited by 97
Terzioglu, G., & Young-Pearse, T. L. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00674-9 · Cited by 91
Choi, Y., Zhang, J., Murga, C., Yu, H., Koller, E., Monia, B. P., Gutkind, J. S., & Li, W. (2002) · Oncogene · doi:10.1038/sj.onc.1205650 · Cited by 93
Downstream of Kinase, p62 dok , Is a Mediator of FcγRIIB Inhibition of FcεRI Signaling
Ott, V. L., Tamir, I., Niki, M., Pandolfi, P. P., & Cambier, J. C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4430 · Cited by 92
Targeting c-Kit mutations: basic science to novel therapies
Sattler, M., & Salgia, R. (2003) · Leukemia Research · doi:10.1016/j.leukres.2003.10.004 · Cited by 92
Coordinate suppression of B cell lymphoma by PTEN and SHIP phosphatases
Miletic, A. V., Anzelon-Mills, A. N., Mills, D. M., Omori, S. A., Pedersen, I. M., Shin, D., Ravetch, J. V., Bolland, S. M., Morse, H. C., & Rickert, R. C. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20091962 · Cited by 87
Fukuda, R.-I., Hayashi, A., Utsunomiya, A., Nukada, Y., Fukui, R., Itoh, K., Tezuka, K., Ohashi, K., Mizuno, K., Sakamoto, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507184102 · Cited by 87
The termination of PI3K signalling by SHIP1 and SHIP2 inositol 5-phosphatases
Backers, K., Bléro, D., Paternotte, N., Zhang, J., & Erneux, C. (2003) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(02)00043-2 · Cited by 85
Pesesse, X., Dewaste, V., Smedt, F. D., Laffargue, M., Giuriato, S., Moreau, C., Payrastre, B., & Erneux, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103537200 · Cited by 82
Fcγ Receptors on Mast Cells: Activatory and Inhibitory Regulation of Mediator Release
Tkaczyk, C., Okayama, Y., Metcalfe, D. D., & Gilfillan, A. M. (2004) · International Archives of Allergy and Immunology · doi:10.1159/000077213 · Cited by 84
Class I PI 3-kinases: Function and evolution
Kriplani, N., Hermida, M. A., Brown, E. R., & Leslie, N. R. (2015) · Advances in Biological Regulation · doi:10.1016/j.jbior.2015.05.002 · Cited by 83
The PI3' Kinase Pathway in Interferon Signaling
Kaur, S., Shahab Uddin, M. S., & Platanias, L. C. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.780 · Cited by 84
Identification of the human erythropoietin receptor region required for Stat1 and Stat3 activation
Kirito, K., Nakajima, K., Watanabe, T., Uchida, M., Tanaka, M., Ozawa, K., & Komatsu, N. (2002) · Blood · doi:10.1182/blood.v99.1.102 · Cited by 82
Harris, S. J., Parry, R. V., Westwick, J. K., & Ward, S. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r700044200 · Cited by 81
Tu, Z., Ninos, J. M., Ma, Z., Wang, J., Lemos, M. P., Desponts, C., Ghansah, T., Howson, J. M., & Kerr, W. G. (2001) · Blood · doi:10.1182/blood.v98.7.2028 · Cited by 82
Phosphoinositide phosphatases in a network of signalling reactions
Bléro, D., Payrastre, B., Schurmans, S., & Erneux, C. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-007-0304-5 · Cited by 82
PI(3,4)P2 Signaling in Cancer and Metabolism
Gozzelino, L., Santis, M. C. D., Gulluni, F., Hirsch, E., & Martini, M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00360 · Cited by 79
Aging of the brain, neurotrophin signaling, and Alzheimer's disease: Is IGF1-R the common culprit?
Puglielli, L. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.01.010 · Cited by 61
Inositol Polyphosphate Phosphatases in Human Disease
Hakim, S., Bertucci, M. C., Conduit, S. E., Vuong, D. L., & Mitchell, C. A. (2012) · Current topics in microbiology and immunology · doi:10.1007/978-94-007-5025-8_12 · Cited by 77
INPP5D regulates inflammasome activation in human microglia
Chou, V., Pearse, R. V., Aylward, A. J., Ashour, N., Taga, M., Terzioglu, G., Fujita, M., Fancher, S. B., Sigalov, A., Benoit, C. R., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42819-w · Cited by 79
Giuriato, S., Pesesse, X., Bodin, S., Sasaki, T., Viala, C., Marion, E., Penninger, J. M., Schurmans, S., Erneux, C., & Payrastre, B. (2003) · Biochemical Journal · doi:10.1042/bj20030581 · Cited by 78
SHIP2 and its involvement in various diseases
Suwa, A., Kurama, T., & Shimokawa, T. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.492780 · Cited by 74
Castranio, E. L., Hasel, P., Haure‐Mirande, J., Ramirez Jimenez, A. V., Hamilton, B. W., Kim, R. D., Glabe, C. G., Wang, M., Zhang, B., Gandy, S., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.12821 · Cited by 74
“10 In particular, SHIP1 inhibits phagocytic signal transduction by triggering receptor expressed on myeloid cells 2 (TREM2) and tyrosine kinase binding protein (TYROBP, also known as DAP12).”
Mechanisms of Transformation by the BCR/ABL Oncogene
Sattler, M., & Griffin, J. D. (2001) · International Journal of Hematology · doi:10.1007/bf02981952 · Cited by 74
Faries, M. B., Bedrosian, I., Xu, S., Koski, G. K., Roros, J. G., Moise, M. A., Nguyen, H. Q., Engels, F. H. C., Cohen, P. A., & Czerniecki, B. J. (2001) · Blood · doi:10.1182/blood.v98.8.2489 · Cited by 74
Aydar, Y., Balogh, P., Tew, J. G., & Szakal, A. K. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.5975 · Cited by 73
Horn, S., Endl, E., Fehse, B., Weck, M. M., Mayr, G. W., & Jücker, M. (2004) · Leukemia · doi:10.1038/sj.leu.2403529 · Cited by 73
The structure of phosphoinositide phosphatases: Insights into substrate specificity and catalysis
Hsu, F., & Mao, Y. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.09.015 · Cited by 74
SHIP's C-terminus is essential for its hydrolysis of PIP3 and inhibition of mast cell degranulation
Damen, J. E., Ware, M. D., Kalesnikoff, J., Hughes, M. R., & Krystal, G. (2001) · Blood · doi:10.1182/blood.v97.5.1343 · Cited by 71
Function of PTEN during the Formation and Maintenance of Neuronal Circuits in the Brain
van Diepen, M. T., & Eickholt, B. J. (2007) · Developmental Neuroscience · doi:10.1159/000109852 · Cited by 73
Identification of Pax2-regulated genes by expression profiling of the mid-hindbrain organizer region
Bouchard, M., Grote, D., Craven, S. E., Sun, Q., Steinlein, P., & Busslinger, M. (2005) · Development · doi:10.1242/dev.01833 · Cited by 68
Galandrini, R., Tassi, I., Mattia, G., Lenti, L., Piccoli, M., Frati, L., & Santoni, A. (2002) · Blood · doi:10.1182/blood-2002-04-1058 · Cited by 69
Lyn, PKC-δ, SHIP-1 interactions regulate GPVI-mediated platelet-dense granule secretion
Chari, R., Kim, S., Murugappan, S., Sanjay, A., Daniel, J. L., & Kunapuli, S. P. (2009) · Blood · doi:10.1182/blood-2008-11-188516 · Cited by 69
Hogan, A., Yakubchyk, Y., Chabot, J., Obagi, C., Daher, E., Maekawa, K., & Gee, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410654200 · Cited by 68
Inpp5f Is a Polyphosphoinositide Phosphatase That Regulates Cardiac Hypertrophic Responsiveness
Zhu, W., Trivedi, C. M., Zhou, D. D., Yuan, L., Lu, M. M., & Epstein, J. A. (2009) · Circulation Research · doi:10.1161/circresaha.109.208785 · Cited by 66
PI3K signaling controls cell fate at many points in B lymphocyte development and activation
Donahue, A. C., & Fruman, D. A. (2004) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2003.12.024 · Cited by 68
Signaling Circuits in Early B-Cell Development
Reth, M. G., & Nielsen, P. (2014) · Advances in immunology · doi:10.1016/b978-0-12-800267-4.00004-3 · Cited by 68
Lam, K. K. W., Chiu, P. C. N., Lee, C., Pang, R. T. K., Leung, C. O. N., Koistinen, H. K., Seppälä, M. T., Ho, P., & Yeung, W. S. B. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.233841 · Cited by 66
Kashiwada, M., Cattoretti, G., McKeag, L., Rouse, T. M., Showalter, B. M., Al‐Alem, U., Niki, M., Pandolfi, P. P., Field, E. H., & Rothman, P. B. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.3958 · Cited by 66
Trotta, R., Chen, L., Costinean, S., Josyula, S., Mundy-Bosse, B. L., Ciarlariello, D., Mao, C., Briercheck, E. L., McConnell, K. K., Mishra, A., et al. (2013) · Blood · doi:10.1182/blood-2012-12-467597 · Cited by 66
Metadata
- Authors
- Rohrschneider, L. R., Fuller, J. F., Wolf, I., Liu, Y., & Lucas, D. M.
- Affiliations
- Fred Hutch Cancer Center (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2000-03-01
- Volume
- 14
- Issue
- 5
- Pages
- 505-520
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2162332365
- Cited by
- 294
- References
- 116
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 3 · 2023: 7 · 2022: 4 · 2021: 3 · 2020: 6 · 2019: 3 · 2018: 5 · 2017: 5 · 2016: 3 · 2015: 6 · 2014: 9 · 2013: 11 · 2012: 16
- Type
- posted content
- Language
- en
- Open access
- closed
- Locations
- Genes & Development (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fred Hutchinson Cancer Research Center
- National Institutes of Health (5r01ca020551-21, 1f32dk009774-01)
- National Cancer Institute (CA20551, CA4987)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK09774)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- hematopoietic cell development, growth factor receptors, signal transduction, transcriptional regulation, transcription factor activation, protein structure-function relationship
- MeSH terms
- Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases, Animals, B-Lymphocytes, Humans, Phosphoric Monoester Hydrolases, src Homology Domains, Protein Isoforms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review